This post was originally published on this site
Pfizer announced earnings per share of $2.04 on revenue of $27.74B. Analysts polled by Investing.com anticipated EPS of $1.71 on revenue of $25.26B.
Pfizer shares are down 12% from the beginning of the year, still down 15.82% from its 52 week high of $61.71 set on December 20, 2021. They are outperforming the S&P Global 100 which is down 13.83% from the start of the year.
Pfizer’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
